Skip to content
10-Q

Quarterly Report

Profound Medical Corp. PROF

0001104659-26-057198

← back to feed
Filed
May 7, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 7, 2026 36.34M sh
Shares Diluted Q1 2026 · Mar 31, 2026 36.3M sh
Shares Diluted Q1 2026 · Mar 31, 2025 30.04M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$8.58M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$8.28M
Short Term Debt Q1 2026 · Mar 31, 2026 $4.5M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $50.3M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $59.72M
Stockholders Equity Q1 2026 · Mar 31, 2026 $59.42M
Stockholders Equity Q1 2026 · Dec 31, 2025 $66.43M
Stockholders Equity Q1 2026 · Mar 31, 2025 $50.79M
Stockholders Equity Q1 2026 · Dec 31, 2024 $60.42M
Current Liabilities Q1 2026 · Mar 31, 2026 $10.61M
Current Liabilities Q1 2026 · Dec 31, 2025 $6.08M
Total Liabilities Q1 2026 · Mar 31, 2026 $14.03M
Total Liabilities Q1 2026 · Dec 31, 2025 $11.04M
Current Assets Q1 2026 · Mar 31, 2026 $69.53M
Current Assets Q1 2026 · Dec 31, 2025 $76.09M
Total Assets Q1 2026 · Mar 31, 2026 $73.46M
Total Assets Q1 2026 · Dec 31, 2025 $77.48M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.19
Eps Diluted Q1 2026 · Mar 31, 2025 $0.36
Eps Basic Q1 2026 · Mar 31, 2026 $0.19
Eps Basic Q1 2026 · Mar 31, 2025 $0.36
Sga Expense Q1 2026 · Mar 31, 2026 $6.59M
Sga Expense Q1 2026 · Mar 31, 2025 $8.21M
Rd Expense Q1 2026 · Mar 31, 2026 $5.26M
Rd Expense Q1 2026 · Mar 31, 2025 $4.81M
Net Income Q1 2026 · Mar 31, 2026 −$7.05M
Net Income Q1 2026 · Mar 31, 2025 −$10.72M
Operating Income Q1 2026 · Mar 31, 2026 −$8.02M
Operating Income Q1 2026 · Mar 31, 2025 −$11.17M
Gross Profit Q1 2026 · Mar 31, 2026 $3.83M
Gross Profit Q1 2026 · Mar 31, 2025 $1.85M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $1.51M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $768K
Long Term Debt Q1 2026 · Dec 31, 2025 $4.5M